Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Outdefine -- The Learning and Execution Layer For Healthcare Systems.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Baobab Studios is a VR animation company that creates story and character driven cinematic experiences.
Night is an operator of a talent management and digital marketing agency intended to specialize in influencer marketing, gaming.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Abivax develops medicines that alter the body's natural immune system mechanisms.
TCG has invested in 148 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. TCG's total known invested capital is $1.4B.
TCG's average investment size is $21.9M across its portfolio of 148 companies.
Recent TCG portfolio additions include Outdefine, Affinia Therapeutics, Judo Bio, Cidara Therapeutics, Disc Medicine. These companies were founded in 2020 or later.